Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Value of routine measurement of serum calcitonin concentrations in patients with nodular thyroid disease: A multicenter study.

Papi G, Corsello SM, Cioni K, Pizzini AM, Corrado S, Carapezzi C, Fadda G, Baldini A, Carani C, Pontecorvi A, Roti E.

J Endocrinol Invest. 2006 May;29(5):427-37.

PMID:
16794366
3.

Lack of elevated serum carcinoembryonic antigen and calcitonin in medullary thyroid carcinoma.

Diez JJ, Iglesias P.

Thyroid. 2004 Nov;14(11):984-5. No abstract available.

PMID:
15678599
4.

Medullary thyroid carcinoma.

Cohen EG, Shaha AR, Rinaldo A, Devaney KO, Ferlito A.

Acta Otolaryngol. 2004 Jun;124(5):544-57. Review. No abstract available.

PMID:
15267170
5.

Lack of elevated serum carcinoembryonic antigen and calcitonin in medullary thyroid carcinoma.

Bockhorn M, Frilling A, Rewerk S, Liedke M, Dirsch O, Schmid KW, Broelsch CE.

Thyroid. 2004 Jun;14(6):468-70.

PMID:
15242577
6.

Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders.

Elisei R, Bottici V, Luchetti F, Di Coscio G, Romei C, Grasso L, Miccoli P, Iacconi P, Basolo F, Pinchera A, Pacini F.

J Clin Endocrinol Metab. 2004 Jan;89(1):163-8.

PMID:
14715844
7.

Distant metastases from thyroid and parathyroid cancer.

Shaha AR, Ferlito A, Rinaldo A.

ORL J Otorhinolaryngol Relat Spec. 2001 Jul-Aug;63(4):243-9. Review.

PMID:
11408821
8.

Routine measurement of serum calcitonin is useful for early detection of medullary thyroid carcinoma in patients with nodular thyroid diseases.

Hahm JR, Lee MS, Min YK, Lee MK, Kim KW, Nam SJ, Yang JH, Chung JH.

Thyroid. 2001 Jan;11(1):73-80.

PMID:
11272100
9.
10.

Evaluation of routine basal serum calcitonin measurement for early diagnosis of medullary thyroid carcinoma in seven hundred seventy-three patients with nodular goiter.

Ozgen AG, Hamulu F, Bayraktar F, Yilmaz C, Tüzün M, Yetkin E, Tunçyürek M, Kabalak T.

Thyroid. 1999 Jun;9(6):579-82.

PMID:
10411120
11.

Routine measurement of plasma calcitonin in nodular thyroid diseases.

Vierhapper H, Raber W, Bieglmayer C, Kaserer K, Weinhäusl A, Niederle B.

J Clin Endocrinol Metab. 1997 May;82(5):1589-93.

PMID:
9141554
12.

Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma.

Pacini F, Fontanelli M, Fugazzola L, Elisei R, Romei C, Di Coscio G, Miccoli P, Pinchera A.

J Clin Endocrinol Metab. 1994 Apr;78(4):826-9.

PMID:
8157706
13.

Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules.

Rieu M, Lame MC, Richard A, Lissak B, Sambort B, Vuong-Ngoc P, Berrod JL, Fombeur JP.

Clin Endocrinol (Oxf). 1995 May;42(5):453-60.

PMID:
7621562
14.
15.

Immunoassay of human calcitonin.

Tashijan AH Jr, Howland BG, Melvin KE, Hill CS Jr.

N Engl J Med. 1970 Oct 22;283(17):890-5. No abstract available.

PMID:
5458052
16.

Medullary thyroid carcinoma: clinicopathologic features and long-term follow-up of 65 patients treated during 1946 through 1970.

Gharib H, McConahey WM, Tiegs RD, Bergstralh EJ, Goellner JR, Grant CS, van Heerden JA, Sizemore GW, Hay ID.

Mayo Clin Proc. 1992 Oct;67(10):934-40.

PMID:
1434853

Supplemental Content

Support Center